doi:10.1002/14651858.CD001044
Dose Escalation Many treatment plans begin with lower doses that increase over time
Complex Hospitalari Universitari Moiss BroggiHospital Universitario La Paz, La Paz University Hospital Research Institute (IdiPAZ), Universidad Autnoma de Madrid 18.Hospital Universitario Virgen de la Victoria de Mlaga 19.Hospital Universitari Parc Taul de Sabadell 20.Complejo Asistencial Universitario de Len 21.Hospital Universitario Central de Asturias E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2542 - ESOC25-1724 LONGITUDINAL TRENDS IN PREVALENCE OF RISK FACTORS AND STROKE RECURRENCE IN PATIENTS WITH FIRST-EVER TRANSIENT ISCHEAMIC ATTACK Outi Kasari 1 , Alexandra Prinz 1 , Silja Rty 1 , Daniel Strbian 1 1 Department of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland, Helsinki, Finland Background and Aims: The incidence of ischaemic stroke (IS) is decreasing in high-income countries, potentially due to changes in management of cardiovascular risk factors
ChaC2 is a constitutively expressed protein whose expression is not affected by the external environment for the basal turnover of GSH [37]
Kisspeptin is not an approved medicine
